Michael Madaio to Anti-Glomerular Basement Membrane Disease
This is a "connection" page, showing publications Michael Madaio has written about Anti-Glomerular Basement Membrane Disease.
Connection Strength
1.356
-
Human anti-a3(IV)NC1 antibody drug conjugates target glomeruli to resolve nephritis. Am J Physiol Renal Physiol. 2015 Oct 15; 309(8):F680-4.
Score: 0.503
-
Modeling of human anti-GBM antibody-alpha3(IV)NC1 interactions predicts antigenic cross-linking through contact of both heavy chains with repeating epitopes on alpha3(IV)NC1. Am J Nephrol. 2009; 30(5):474-80.
Score: 0.335
-
High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to alpha3(IV)NC1 collagen. Kidney Int. 2000 Jul; 58(1):115-22.
Score: 0.176
-
Human Goodpasture anti-alpha3(IV)NC1 autoantibodies share structural determinants. Kidney Int. 1998 Feb; 53(2):402-7.
Score: 0.149
-
Amino acid metabolism inhibits antibody-driven kidney injury by inducing autophagy. J Immunol. 2015 Jun 15; 194(12):5713-24.
Score: 0.124
-
Goodpasture syndrome involving overlap with Wegener's granulomatosis and anti-glomerular basement membrane disease. J Am Soc Nephrol. 1997 Nov; 8(11):1795-800.
Score: 0.037
-
Anti-alpha1(IV) collagen autoantibodies associated with lung adenocarcinoma presenting as the Goodpasture syndrome. Ann Intern Med. 1996 Apr 01; 124(7):651-3.
Score: 0.033